Literature DB >> 21327015

Permanent complete heart block following surgical correction of congenital heart disease.

F Edwin1, E Aniteye, M Tettey, L Sereboe, D Kotei, M Tamatey, K Entsua-Mensah, K Frimpong-Boateng.   

Abstract

BACKGROUND: The risk of complete heart block (CHB) from congenital heart repairs in Ghana is unknown. This information is important for referring physicians and in pre-operative counselling of patients and facilitates the process of obtaining informed consent for such repairs.
OBJECTIVES: This study was undertaken to determine the incidence of permanent post-operative CHB requiring pacemaker implantation; and the post-operative problems related to the pacemaker.
DESIGN: Retrospective study design.
SETTING: The National Cardiothoracic Centre (NCTC), Korle-Bu Teaching Hospital, Accra, Ghana.
METHOD: Review of all patients who had intra-cardiac repair of congenital heart disease known to predispose to post-operative complete heart block from January 1993 to December 2008 was carried out with computation of the frequency of complete heart block according to the intra-operative diagnoses.
RESULTS: Six out of 242 patients (2.5%) developed permanent post-operative CHB. All underwent closure of a large perimembranous ventricular septal defect (VSD) either as an isolated defect (2 of 151 or 1.3%) or in the setting of conotruncal anomalies (4 of 73 or 5.5%). The dominant parental concern relating to the implanted device was the financial implications of future multiple surgeries to replace a depleted pulse generator.
CONCLUSION: Permanent post-operative complete heart block occurred in 1.3% of patients undergoing VSD repair and 5.5% of those undergoing repair of conotruncal anomalies (Fallot's tetralogy). The dominant anatomic risk factor was a large perimembranous VSD as an isolated defect or as part of a conotruncal anomaly. Permanent pacemaker implantation in this setting is attended by a low morbidity.

Entities:  

Keywords:  Complete Heart Block; Congenital heart defect; Morbidity; Pacemaker; Ventricular Septal Defect

Year:  2010        PMID: 21327015      PMCID: PMC2996844          DOI: 10.4314/gmj.v44i3.68894

Source DB:  PubMed          Journal:  Ghana Med J        ISSN: 0016-9560


  19 in total

1.  Anatomy of the atrioventricular conduction system in ventricular septal defect.

Authors:  J L TITUS; G W DAUGHERTY; J E EDWARDS
Journal:  Circulation       Date:  1963-07       Impact factor: 29.690

2.  The architecture of the conduction system in congenital heart disease. III. Ventricular septal defect.

Authors:  M LEV
Journal:  Arch Pathol       Date:  1960-11

3.  The architecture of the conduction system in congenital heart disease. II. Tetralogy of Fallot.

Authors:  M LEV
Journal:  AMA Arch Pathol       Date:  1959-05

4.  Histology of the atrial portion of the cardiac conduction system in man and other mammals.

Authors:  W M COPENHAVER; R C TRUEX
Journal:  Anat Rec       Date:  1952-12

5.  Twenty years experience with pediatric pacing: epicardial and transvenous stimulation.

Authors:  J S Sachweh; J F Vazquez-Jimenez; F A Schöndube; S H Daebritz; H Dörge; E G Mühler; B J Messmer
Journal:  Eur J Cardiothorac Surg       Date:  2000-04       Impact factor: 4.191

6.  Postoperative complete heart block in children.

Authors:  R J Fryda; S Kaplan; J A Helmsworth
Journal:  Br Heart J       Date:  1971-07

7.  Is complete heart block after surgical closure of ventricular septum defects still an issue?

Authors:  Henrik Ø Andersen; Marc R de Leval; Victor T Tsang; Martin J Elliott; Robert H Anderson; Andrew C Cook
Journal:  Ann Thorac Surg       Date:  2006-09       Impact factor: 4.330

8.  Abnormalities of conduction after total correction of Fallot's tetralogy: a prospective study.

Authors:  A Hussain; A Malik; A Jalal; M Rehman
Journal:  J Pak Med Assoc       Date:  2002-02       Impact factor: 0.781

9.  Variations in the morphology of the ventricular septal defect and disposition of the atrioventricular conduction tissues in tetralogy of Fallot.

Authors:  D F Dickinson; J L Wilkinson; A Smith; D I Hamilton; R H Anderson
Journal:  Thorac Cardiovasc Surg       Date:  1982-10       Impact factor: 1.827

10.  Pacing activity, patient and lead survival over 20 years of permanent epicardial pacing in children.

Authors:  John D R Thomson; Michael E Blackburn; Carin Van Doorn; Ann Nicholls; Kevin G Watterson
Journal:  Ann Thorac Surg       Date:  2004-04       Impact factor: 4.330

View more
  7 in total

Review 1.  Cardiothoracic surgical experience in Ghana.

Authors:  Mark Tettey; Martin Tamatey; Frank Edwin
Journal:  Cardiovasc Diagn Ther       Date:  2016-10

2.  Management of postoperative arrhythmias in pediatric patients.

Authors:  Yaniv Bar-Cohen; Michael J Silka
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-10

Review 3.  Radiologic evaluation of coronary artery disease in adults with congenital heart disease.

Authors:  David M Valenzuela; Karen G Ordovas
Journal:  Int J Cardiovasc Imaging       Date:  2015-09-05       Impact factor: 2.357

4.  The development of cardiac surgery in West Africa--the case of Ghana.

Authors:  Frank Edwin; Mark Tettey; Ernest Aniteye; Martin Tamatey; Lawrence Sereboe; Kow Entsua-Mensah; David Kotei; Kofi Baffoe-Gyan
Journal:  Pan Afr Med J       Date:  2011-06-06

5.  Percutaneous closure of perimembranous ventricular septal defect using patent ductus arteriosus occluders.

Authors:  Hieu Lan Nguyen; Quang Tan Phan; Dung Duc Doan; Linh Huynh Dinh; Hieu Ba Tran; Saima Sharmin; Julian Johny Thottian; Hoyoun Won; Wang Soo Lee; Seung Yong Shin; Truong Quang Nguyen; Sang Wook Kim
Journal:  PLoS One       Date:  2018-11-15       Impact factor: 3.240

6.  Anesthetic management of a 2-day-old with complete congenital heart block.

Authors:  Puneet Khanna; Shubhangi Arora; Ajisha Aravindan; Ganga Prasad
Journal:  Saudi J Anaesth       Date:  2014-01

7.  Short- and Long-term Outcome After Interventional VSD Closure: A Single-Center Experience in Pediatric and Adult Patients.

Authors:  F Berger; S Schubert; M Bergmann; C P Germann; J Nordmeyer; B Peters
Journal:  Pediatr Cardiol       Date:  2020-10-03       Impact factor: 1.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.